These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 23715726

  • 1. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Yoshizaki T, Morino K, Kume S, Kashiwagi A, Maegawa H.
    Am J Physiol Endocrinol Metab; 2013 Jul 15; 305(2):E293-304. PubMed ID: 23715726
    [Abstract] [Full Text] [Related]

  • 2. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T, Watanabe M, Horai Y, Kaneko-Iwasaki N, Arita E, Miyazaki T, Morimoto K, Honda A, Irie J, Itoh H.
    Endocrinology; 2014 Aug 15; 155(8):2810-9. PubMed ID: 24773344
    [Abstract] [Full Text] [Related]

  • 3. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, Mori S, Tokuyama K, Kubota N, Kadowaki T, Terauchi Y.
    Metabolism; 2011 May 15; 60(5):617-28. PubMed ID: 20673929
    [Abstract] [Full Text] [Related]

  • 4. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, van Heek M, Hwa JJ.
    Eur J Pharmacol; 2008 Apr 14; 584(1):118-24. PubMed ID: 18329014
    [Abstract] [Full Text] [Related]

  • 5. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
    Wang X, Ren Q, Wu T, Guo Y, Liang Y, Liu S.
    Mol Med Rep; 2014 Dec 14; 10(6):2917-23. PubMed ID: 25310357
    [Abstract] [Full Text] [Related]

  • 6. Ezetimibe increases hepatic iron levels in mice fed a high-fat diet.
    Kishino Y, Tanaka Y, Ikeda T, Yamamoto K, Ogawa H, Iwatani Y, Kamisako T.
    J Pharmacol Exp Ther; 2013 Jun 14; 345(3):483-91. PubMed ID: 23538201
    [Abstract] [Full Text] [Related]

  • 7. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
    Crescenzo R, Bianco F, Coppola P, Mazzoli A, Tussellino M, Carotenuto R, Liverini G, Iossa S.
    Exp Physiol; 2014 Sep 14; 99(9):1203-13. PubMed ID: 24972835
    [Abstract] [Full Text] [Related]

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 14; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 9. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
    Yamazaki T, Kishimoto K, Miura S, Ezaki O.
    J Nutr Biochem; 2012 Feb 14; 23(2):123-32. PubMed ID: 21447441
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 14; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 11. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
    Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T.
    Endocrinology; 2010 May 14; 151(5):2040-9. PubMed ID: 20211973
    [Abstract] [Full Text] [Related]

  • 12. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610
    [Abstract] [Full Text] [Related]

  • 13. [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice].
    Zhu ML, Liu J, Liu YL, Yang WJ, Luo Y, Zhuang ZJ, Jiao QB, Chen JY, Yan J, Bian DX, Ma XJ, Xun YH, Shi JP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct 15; 27(5):325-7. PubMed ID: 24645313
    [Abstract] [Full Text] [Related]

  • 14. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
    Wada T, Miyashita Y, Sasaki M, Aruga Y, Nakamura Y, Ishii Y, Sasahara M, Kanasaki K, Kitada M, Koya D, Shimano H, Tsuneki H, Sasaoka T.
    Am J Physiol Endocrinol Metab; 2013 Dec 01; 305(11):E1415-25. PubMed ID: 24129399
    [Abstract] [Full Text] [Related]

  • 15. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
    Vitto MF, Luz G, Luciano TF, Marques SO, Souza DR, Pinho RA, Lira FS, Cintra DE, De Souza CT.
    Horm Metab Res; 2012 Nov 01; 44(12):885-90. PubMed ID: 22932913
    [Abstract] [Full Text] [Related]

  • 16. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S, Hong J, Jeon R, Kim HS.
    Nutr Res; 2016 Jan 01; 36(1):90-100. PubMed ID: 26773785
    [Abstract] [Full Text] [Related]

  • 17. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
    Santos IB, de Bem GF, Cordeiro VSC, da Costa CA, de Carvalho LCRM, da Rocha APM, da Costa GF, Ognibene DT, de Moura RS, Resende AC.
    Nutr Res; 2017 Jul 01; 43():69-81. PubMed ID: 28739056
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885
    [Abstract] [Full Text] [Related]

  • 19. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.
    Valdecantos MP, Pérez-Matute P, González-Muniesa P, Prieto-Hontoria PL, Moreno-Aliaga MJ, Martínez JA.
    J Nutr Biochem; 2012 Dec 15; 23(12):1676-84. PubMed ID: 22464149
    [Abstract] [Full Text] [Related]

  • 20. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, Gärttner S, Spruss A, Huber O, Bergheim I.
    J Nutr Biochem; 2015 Nov 15; 26(11):1183-92. PubMed ID: 26168700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.